- <![CDATA[ctDNA in Metastatic Urothelial Carcinoma]]><![CDATA[Experts explain how ctDNA tracking in metastatic cancer helps tailor immunotherapy, spot relapse early, and guide dose breaks—plus key limitations.]]>onclive · 2mo ago↗ source
- <![CDATA[Institutional Perspectives on Treatment Thresholds in PLGG]]><![CDATA[Experts weigh PLGG treatment choices, balancing chemo and MEK inhibitors, guided by vision decline, symptoms, tumor growth, and family logistics.]]>onclive · 2mo ago↗ source
- <![CDATA[Renal Cell Carcinoma: Practical Treatment Selection Across Risk Groups]]><![CDATA[In this segment, Dr. Elizabeth Plimack leads a discussion with Dr. Sundhar Ramalingam and Dr. Yasser Ged on how clinicians approach treatment selection in renal cell carcinoma across diffe…onclive